A catalytically and genetically optimized β-lactamase-matrix based assay for sensitive, specific, and higher throughput analysis of native henipavirus entry characteristics

Virology Journal

Volumn 6, Issue , 2009, Pages

  Wolf, Mike C ^a   Wang, Yao ^a   Freiberg, Alexander N ^c   Aguilar, Hector C ^a   Holbrook, Michael R ^c   Lee, Benhur ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAMASE; EPHRIN B2; MATRIX PROTEIN; VIRUS ENVELOPE PROTEIN; VIRUS FUSION PROTEIN; CCF 2; FLUORESCEIN DERIVATIVE; HYBRID PROTEIN; LACTAM; VIROSOME;

ARTICLE; CATALYSIS; CONTROLLED STUDY; ENZYME ASSAY; ENZYME SYNTHESIS; GENE EXPRESSION; GENE MUTATION; HENDRA VIRUS; HENIPAVIRUS; NIPAH VIRUS; NONHUMAN; NUCLEOTIDE SEQUENCE; PARAMYXOVIRUS; PROTEIN CLEAVAGE; SENSITIVITY AND SPECIFICITY; VIRUS ENTRY; VIRUS LIKE AGENT; VIRUS MORPHOLOGY; ANIMAL; ECONOMICS; GENETICS; HAZARDOUS WASTE; METABOLISM; METHODOLOGY; PHYSIOLOGY; REPORTER GENE;

BACTERIA (MICROORGANISMS); HENDRA VIRUS; HENIPAVIRUS; MAMMALIA; NIPAH VIRUS;

ANIMALS; BETA-LACTAMASES; CONTAINMENT OF BIOHAZARDS; FLUORESCEINS; GENES, REPORTER; HENIPAVIRUS; LACTAMS; RECOMBINANT FUSION PROTEINS; VIRAL MATRIX PROTEINS; VIROSOMES; VIRUS INTERNALIZATION;

EID: 69049114100     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-6-119     Document Type: Article

References (56)

1. Infection of humans and horses by a newly described morbillivirus. LA Selvey RM Wells JG McCormack AJ Ansford K Murray RJ Rogers PS Lavercombe P Selleck JW Sheridan, Med J Aust 1995 162 642 645 7603375
2. The natural history of Hendra and Nipah viruses. H Field P Young JM Yob J Mills L Hall J Mackenzie, Microbes Infect 2001 3 307 314 10.1016/S1286-4579(01) 01384-3 11334748
3. Fatal encephalitis due to novel paramyxovirus transmitted from horses. JD O'Sullivan AM Allworth DL Paterson TM Snow R Boots LJ Gleeson AR Gould AD Hyatt J Bradfield, Lancet 1997 349 93 95 10.1016/S0140-6736(96)06162-4 8996421
4. Pathobiology of henipavirus entry: insights into therapeutic strategies. MC Wolf OA Negrete B Lee, Future Virology 2007 2 3 267 282 10.2217/17460794.2.3. 267
5. Membrane fusion tropism and heterotypic functional activities of the Nipah virus and Hendra virus envelope glycoproteins. KN Bossart LF Wang MN Flora KB Chua SK Lam BT Eaton CC Broder, J Virol 2002 76 11186 11198 10.1128/JVI.76.22.11186-11198.2002 12388678
6. Subcellular localization and calcium and pH requirements for proteolytic processing of the Hendra virus fusion protein. CT Pager MA Wurth RE Dutch, J Virol 2004 78 9154 9163 10.1128/JVI.78.17.9154-9163.2004 15308711
7. Influence of N-glycans on processing and biological activity of the nipah virus fusion protein. M Moll A Kaufmann A Maisner, J Virol 2004 78 7274 7278 10.1128/JVI.78.13.7274-7278.2004 15194804
8. EphrinB2 is the entry receptor for Nipah virus, an emergent deadly paramyxovirus. OA Negrete EL Levroney HC Aguilar A Bertolotti-Ciarlet R Nazarian S Tajyar B Lee, Nature 2005 436 401 405 16007075
9. Two key residues in ephrinB3 are critical for its use as an alternative receptor for Nipah virus. OA Negrete MC Wolf HC Aguilar S Enterlein W Wang E Muhlberger SV Su A Bertolotti-Ciarlet R Flick B Lee, PLoS Pathog 2006 2 e7 10.1371/journal.ppat.0020007 16477309
10. N-glycans on Nipah virus fusion protein protect against neutralization but reduce membrane fusion and viral entry. HC Aguilar KA Matreyek CM Filone ST Hashimi EL Levroney OA Negrete A Bertolotti-Ciarlet DY Choi I McHardy JA Fulcher, J Virol 2006 80 4878 4889 10.1128/JVI.80.10.4878-4889.2006 16641279
11. Molecular mechanism of paramyxovirus budding. T Takimoto A Portner, Virus Res 2004 106 133 145 10.1016/j.virusres.2004.08.010 15567493
12. Escaping from the cell: assembly and budding of negative-strand RNA viruses. AP Schmitt RA Lamb, Curr Top Microbiol Immunol 2004 283 145 196 15298170
13. Role of matrix and fusion proteins in budding of Sendai virus. T Takimoto KG Murti T Bousse RA Scroggs A Portner, J Virol 2001 75 11384 11391 10.1128/JVI.75.23.11384-11391.2001 11689619
14. Paramyxovirus Sendai virus-like particle formation by expression of multiple viral proteins and acceleration of its release by C protein. F Sugahara T Uchiyama H Watanabe Y Shimazu M Kuwayama Y Fujii K Kiyotani A Adachi N Kohno T Yoshida T Sakaguchi, Virology 2004 325 1 10 10.1016/j.virol.2004.04.019 15231380
15. Human parainfluenza virus type 1 matrix and nucleoprotein genes transiently expressed in mammalian cells induce the release of virus-like particles containing nucleocapsid-like structures. EC Coronel KG Murti T Takimoto A Portner, J Virol 1999 73 7035 7038 10400805
16. Vesicular release of ebola virus matrix protein VP40. J Timmins S Scianimanico G Schoehn W Weissenhorn, Virology 2001 283 1 6 10.1006/viro.2001. 0860 11312656
17. Ebola virus VP40 drives the formation of virus-like filamentous particles along with GP. T Noda H Sagara E Suzuki A Takada H Kida Y Kawaoka, J Virol 2002 76 4855 4865 10.1128/JVI.76.10.4855-4865.2002 11967302
18. Ebola virus VP40-induced particle formation and association with the lipid bilayer. LD Jasenosky G Neumann I Lukashevich Y Kawaoka, J Virol 2001 75 5205 5214 10.1128/JVI.75.11.5205-5214.2001 11333902
19. Budding of rabies virus particles in the absence of the spike glycoprotein. T Mebatsion M Konig KK Conzelmann, Cell 1996 84 941 951 10.1016/S0092-8674(00)81072-7 8601317
20. Paramyxoviridae: the viruses and their replication. RA Lamb D Kolakofsky, Fields Virology Fourth edition. Philadelphia: Lippincott Williams and Wilkins, Knipe D, MaH PM, 2001 689 724
21. Quantitative analysis of Nipah virus proteins released as virus-like particles reveals central role for the matrix protein. JR Patch G Crameri LF Wang BT Eaton CC Broder, Virol J 2007 4 1 10.1186/1743-422X-4-1 17204159
22. Mutation of YMYL in the Nipah virus Matrix Protein Abrogates Budding and Alters Subcellular Localization. MJ Ciancanelli CF Basler, J Virol 2006 80 12070 12078 10.1128/JVI.01743-06 17005661
23. Nucleocapsid incorporation into parainfluenza virus is regulated by specific interaction with matrix protein. EC Coronel T Takimoto KG Murti N Varich A Portner, J Virol 2001 75 1117 1123 10.1128/JVI.75.3.1117-1123.2001 11152484
24. Late budding domains and host proteins in enveloped virus release. PD Bieniasz, Virology 2006 344 55 63 10.1016/j.virol.2005.09.044 16364736
25. Evidence for a new viral late-domain core sequence, FPIV, necessary for budding of a paramyxovirus. AP Schmitt GP Leser E Morita WI Sundquist RA Lamb, J Virol 2005 79 2988 2997 10.1128/JVI.79.5.2988-2997.2005 15709019
26. Novel fluorogenic substrates for imaging beta-lactamase gene expression. W Gao B Xing RY Tsien J Rao, J Am Chem Soc 2003 125 11146 11147 10.1021/ja036126o 16220906
27. beta-lactamase as a marker for gene expression in live zebrafish embryos. E Raz G Zlokarnik RY Tsien W Driever, Dev Biol 1998 203 290 294 10.1006/dbio.1998.8999 9808780
28. Quantitation of transcription and clonal selection of single living cells with beta-lactamase as reporter. G Zlokarnik PA Negulescu TE Knapp L Mere N Burres L Feng M Whitney K Roemer RY Tsien, Science 1998 279 84 88 10.1126/science.279.5347.84 9417030
29. Functional characterization of Ebola virus L-domains using VSV recombinants. T Irie JM Licata RN Harty, Virology 2005 336 291 298 10.1016/j.virol.2005.03.027 15892969
30. Budding of PPxY-containing rhabdoviruses is not dependent on host proteins TGS101 and VPS4A. T Irie JM Licata JP McGettigan MJ Schnell RN Harty, J Virol 2004 78 2657 2665 10.1128/JVI.78.6.2657-2665.2004 14990685
31. A bipartite late-budding domain in human immunodeficiency virus type 1. J Martin-Serrano PD Bieniasz, J Virol 2003 77 12373 12377 10.1128/JVI.77.22. 12373-12377.2003 14581576
32. Context-dependent effects of L domains and ubiquitination on viral budding. J Martin-Serrano D Perez-Caballero PD Bieniasz, J Virol 2004 78 5554 5563 10.1128/JVI.78.11.5554-5563.2004 15140952
33. A PPxY motif within the VP40 protein of Ebola virus interacts physically and functionally with a ubiquitin ligase: implications for filovirus budding. RN Harty ME Brown G Wang J Huibregtse FP Hayes, Proc Natl Acad Sci USA 2000 97 13871 13876 10.1073/pnas.250277297 11095724
34. A proline-rich motif within the matrix protein of vesicular stomatitis virus and rabies virus interacts with WW domains of cellular proteins: implications for viral budding. RN Harty J Paragas M Sudol P Palese, J Virol 1999 73 2921 2929 10074141
35. Interactions of normal and mutant vesicular stomatitis virus matrix proteins with the plasma membrane and nucleocapsids. LD Chong JK Rose, J Virol 1994 68 441 447 8254754
36. Henipaviruses. BT Eaton JS Mackenzie LF Wang, Fields Virology Fifth edition. Philadelphia: Lippincott Williams and Wilkins, Knipe D, MaH PM, 2007 1587 1598
37. Polybasic KKR Motif in the Cytoplasmic Tail of Nipah Virus Fusion Protein Modulates Membrane Fusion by Inside-Out Signaling. HC Aguilar KA Matreyek DY Choi CM Filone S Young B Lee, J Virology 2007 81 4520 4532 10.1128/JVI.02205-06 17301148
38. Nipah virus infection: pathology and pathogenesis of an emerging paramyxoviral zoonosis. KT Wong WJ Shieh S Kumar K Norain W Abdullah J Guarner CS Goldsmith KB Chua SK Lam CT Tan, Am J Pathol 2002 161 2153 2167 12466131
39. Single amino acid changes in the Nipah and Hendra virus attachment glycoprotein distinguishes ephrinB2 from ephrinB3 usage. OA Negrete D Chu HC Aguilar B Lee, J Virol 2007 81 10804 10814 10.1128/JVI.00999-07 17652392
40. Functional studies of host-specific ephrin-B ligands as Henipavirus receptors. KN Bossart M Tachedjian JA McEachern G Crameri Z Zhu DS Dimitrov CC Broder LF Wang, Virology 2007 372 357 371 10.1016/j.virol.2007.11.011 18054977
41. A gene atlas of the mouse and human protein-encoding transcriptomes. AI Su T Wiltshire S Batalov H Lapp KA Ching D Block J Zhang R Soden M Hayakawa G Kreiman, Proc Natl Acad Sci USA 2004 101 6062 6067 10.1073/pnas.0400782101 15075390
42. Clinical features of Nipah virus encephalitis among pig farmers in Malaysia. KJ Goh CT Tan NK Chew PS Tan A Kamarulzaman SA Sarji KT Wong BJ Abdullah KB Chua SK Lam, N Engl J Med 2000 342 1229 1235 10.1056/ NEJM200004273421701 10781618
43. Catalytic properties of class A beta-lactamases: efficiency and diversity. A Matagne J Lamotte-Brasseur JM Frere, Biochem J 1998 330 Pt 2 581 598 9480862
44. Site-specific introduction of an electroactive label into a non-electroactive enzyme (beta-lactamase I). K Di Gleria CM Halliwell C Jacob HA Hill, FEBS Lett 1997 400 155 157 10.1016/S0014-5793(96)01373-7 9001388
45. Effects of site-specific mutagenesis of tyrosine 105 in a class A beta-lactamase. WA Escobar J Miller AL Fink, Biochem J 1994 303 Pt 2 555 558 7980417
46. Site-saturation mutagenesis of Tyr-105 reveals its importance in substrate stabilization and discrimination in TEM-1 beta-lactamase. N Doucet PY De Wals JN Pelletier, J Biol Chem 2004 279 46295 46303 10.1074/jbc.M407606200 15326193
47. Paramyxovirus M proteins: pulling it all together and taking it on the road. ME Peeples, The Paramyxoviruses New York: Plenum, Kingsbury DW, 1991 427 456
48. A sensitive and specific enzyme-based assay detecting HIV-1 virion fusion in primary T lymphocytes. M Cavrois C De Noronha WC Greene, Nat Biotechnol 2002 20 1151 1154 10.1038/nbt745 12355096
49. Studies of ebola virus glycoprotein-mediated entry and fusion by using pseudotyped human immunodeficiency virus type 1 virions: involvement of cytoskeletal proteins and enhancement by tumor necrosis factor alpha. A Yonezawa M Cavrois WC Greene, J Virol 2005 79 918 926 10.1128/JVI.79.2.918-926.2005 15613320
50. Folate receptor alpha and caveolae are not required for Ebola virus glycoprotein-mediated viral infection. G Simmons AJ Rennekamp N Chai LH Vandenberghe JL Riley P Bates, J Virol 2003 77 13433 13438 10.1128/JVI.77.24. 13433-13438.2003 14645601
51. Cytoplasmic domain requirement for incorporation of a foreign envelope protein into vesicular stomatitis virus. RJ Owens JK Rose, J Virol 1993 67 360 365 8093220
52. Recombinant vesicular stomatitis virus expressing respiratory syncytial virus (RSV) glycoproteins: RSV fusion protein can mediate infection and cell fusion. JS Kahn MJ Schnell L Buonocore JK Rose, Virology 1999 254 81 91 10.1006/viro.1998.9535 9927576
53. A system for functional analysis of Ebola virus glycoprotein. A Takada C Robison H Goto A Sanchez KG Murti MA Whitt Y Kawaoka, Proc Natl Acad Sci USA 1997 94 14764 14769 10.1073/pnas.94.26.14764 9405687
54. Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses. SM Jones H Feldmann U Stroher JB Geisbert L Fernando A Grolla HD Klenk NJ Sullivan VE Volchkov EA Fritz, Nat Med 2005 11 786 790 10.1038/nm1258 15937495
55. Centrifugal enhancement of human immunodeficiency virus (HIV) and human herpesvirus type 6 (HHV-6) infection in vitro. GR Pietroboni GB Harnett MR Bucens, J Virol Methods 1989 24 85 90 10.1016/0166-0934(89)90010-4 2668317
56. Human immunodeficiency virus type 1 spinoculation enhances infection through virus binding. U O'Doherty WJ Swiggard MH Malim, J Virol 2000 74 10074 10080 10.1128/JVI.74.21.10074-10080.2000 11024136